Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1993 Mar;217(3):207–225.

Clinical decision-making in early breast cancer.

C M Balch 1, S E Singletary 1, K I Bland 1
PMCID: PMC1242772  PMID: 8383953

Abstract

OBJECTIVE: This in-depth review of the multidisciplinary approach to early breast cancer treatment (in situ, stage I and II) will update the surgeon about the indications, risks, and benefits of breast surgery, radiation therapy, adjuvant chemotherapy and hormonal therapy, and the importance of breast reconstructive surgery. SUMMARY BACKGROUND DATA: Breast cancer will occur in one of eight women in the United States during their lifetime and is the second leading cause of death in women from cancer. The practice of multidisciplinary breast cancer treatment has become the standard of care for the majority of breast cancer patients. If the surgeon is to retain the primary coordinating role in breast cancer management, then he or she must fully understand all modalities of oncology therapy and know how to deploy them to benefit individual patients. CONCLUSIONS: This article provides a framework for making clinical decisions about the appropriate combination and sequence of treatment for various presentations of early breast cancer.

Full text

PDF
207

Images in this article

213Figure 4.
on p.213

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman L. V., Katzenstein A. L. The concept of minimal breast cancer and the pathologist's role in the diagnosis of "early carcinoma". Cancer. 1977 Jun;39(6 Suppl):2755–2763. doi: 10.1002/1097-0142(197706)39:6<2755::aid-cncr2820390663>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  2. Andersen J. A. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer. 1977 Jun;39(6):2597–2602. doi: 10.1002/1097-0142(197706)39:6<2597::aid-cncr2820390644>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  3. Anderson D. E., Badzioch M. D. Combined effect of family history and reproductive factors on breast cancer risk. Cancer. 1989 Jan 15;63(2):349–353. doi: 10.1002/1097-0142(19890115)63:2<349::aid-cncr2820630225>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  4. Anderson D. E., Badzioch M. D. Risk of familial breast cancer. Cancer. 1985 Jul 15;56(2):383–387. doi: 10.1002/1097-0142(19850715)56:2<383::aid-cncr2820560230>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  5. Ashikari R., Hajdu S. I., Robbins G. F. Intraductal carcinoma of the breast. (1960-1969). Cancer. 1971 Nov;28(5):1182–1187. doi: 10.1002/1097-0142(1971)28:5<1182::aid-cncr2820280515>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  6. Atkins H., Hayward J. L., Klugman D. J., Wayte A. B. Treatment of early breast cancer: a report after ten years of a clinical trial. Br Med J. 1972 May 20;2(5811):423–429. doi: 10.1136/bmj.2.5811.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Azavedo E., Svane G., Auer G. Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions. Lancet. 1989 May 13;1(8646):1033–1036. doi: 10.1016/s0140-6736(89)92441-0. [DOI] [PubMed] [Google Scholar]
  8. Baker R. R., Kuhajda F. P. The clinical management of a normal contralateral breast in patients with lobular breast cancer. Ann Surg. 1989 Oct;210(4):444–448. doi: 10.1097/00000658-198910000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Balch C. M., Singletary S. E. Adjuvant therapy for node-negative breast cancer patients. Who benefits? Arch Surg. 1988 Oct;123(10):1189–1190. doi: 10.1001/archsurg.1988.01400340015001. [DOI] [PubMed] [Google Scholar]
  10. Bartelink H., van Dam F., van Dongen J. Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Phys. 1985 Feb;11(2):381–385. doi: 10.1016/0360-3016(85)90161-0. [DOI] [PubMed] [Google Scholar]
  11. Beadle G. F., Come S., Henderson I. C., Silver B., Hellman S., Harris J. R. The effect of adjuvant chemotherapy on the cosmetic results after primary radiation treatment for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2131–2137. doi: 10.1016/0360-3016(84)90213-x. [DOI] [PubMed] [Google Scholar]
  12. Boice J. D., Jr, Harvey E. B., Blettner M., Stovall M., Flannery J. T. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992 Mar 19;326(12):781–785. doi: 10.1056/NEJM199203193261201. [DOI] [PubMed] [Google Scholar]
  13. Borger J. H., Keijser A. H. Conservative breast cancer treatment: analysis of cosmetic results and the role of concomitant adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 1987 Aug;13(8):1173–1177. doi: 10.1016/0360-3016(87)90191-x. [DOI] [PubMed] [Google Scholar]
  14. Bornstein B. A., Recht A., Connolly J. L., Schnitt S. J., Cady B., Koufman C., Love S., Osteen R. T., Harris J. R. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer. 1991 Jan 1;67(1):7–13. doi: 10.1002/1097-0142(19910101)67:1<7::aid-cncr2820670103>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  15. Boyages J., Recht A., Connolly J. L., Schnitt S. J., Gelman R., Kooy H., Love S., Osteen R. T., Cady B., Silver B. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol. 1990 Sep;19(1):29–41. doi: 10.1016/0167-8140(90)90163-q. [DOI] [PubMed] [Google Scholar]
  16. Bradley S. J., Weaver D. W., Bouwman D. L. Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome. Am Surg. 1990 Jul;56(7):428–432. [PubMed] [Google Scholar]
  17. Brown P. W., Silverman J., Owens E., Tabor D. C., Terz J. J., Lawrence W., Jr Intraductal "noninfiltrating" carcinoma of the breast. Arch Surg. 1976 Oct;111(10):1063–1067. doi: 10.1001/archsurg.1976.01360280021003. [DOI] [PubMed] [Google Scholar]
  18. Buzdar A. U., McNeese M. D., Hortobagyi G. N., Smith T. L., Kau S., Fraschini G., Hug V., Ellerbroek N., Holmes F. A., Ames F. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer. 1990 Feb 1;65(3):394–399. doi: 10.1002/1097-0142(19900201)65:3<394::aid-cncr2820650303>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  19. Carbone P. P. Breast cancer adjuvant therapy. Cancer. 1990 Sep 15;66(6 Suppl):1378–1386. doi: 10.1002/1097-0142(19900915)66:14+<1378::aid-cncr2820661413>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  20. Carter C. L., Allen C., Henson D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989 Jan 1;63(1):181–187. doi: 10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  21. Carter D., Smith R. R. Carcinoma in situ of the breast. Cancer. 1977 Sep;40(3):1189–1193. doi: 10.1002/1097-0142(197709)40:3<1189::aid-cncr2820400330>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  22. Cascinelli N., Singletary E., Greco M., Ames F., Testori A., Baldini M., Morabito A., Bufalino R., Shallenberger R., Guinee V. Long-term survival and prognostic factors for 2170 breast cancer patients treated at two cancer centers (Milan and Houston). Tumori. 1989 Apr 30;75(2):123–131. doi: 10.1177/030089168907500209. [DOI] [PubMed] [Google Scholar]
  23. Ciatto S., Pacini P., Andreoli C., Cecchini S., Iossa A., Grazzini G., Buranelli F., Campa T., Costa A., Magni A. Chest X-ray survey in the follow-up of breast cancer patients. Br J Cancer. 1989 Jul;60(1):102–103. doi: 10.1038/bjc.1989.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Clark G. M., Dressler L. G., Owens M. A., Pounds G., Oldaker T., McGuire W. L. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med. 1989 Mar 9;320(10):627–633. doi: 10.1056/NEJM198903093201003. [DOI] [PubMed] [Google Scholar]
  25. Clark R. M., McCulloch P. B., Levine M. N., Lipa M., Wilkinson R. H., Mahoney L. J., Basrur V. R., Nair B. D., McDermot R. S., Wong C. S. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992 May 6;84(9):683–689. doi: 10.1093/jnci/84.9.683. [DOI] [PubMed] [Google Scholar]
  26. Clark R. M., Wilkinson R. H., Miceli P. N., MacDonald W. D. Breast cancer. Experiences with conservation therapy. Am J Clin Oncol. 1987 Dec;10(6):461–468. doi: 10.1097/00000421-198712000-00001. [DOI] [PubMed] [Google Scholar]
  27. Coit D. G., Peters M., Brennan M. F. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg. 1991 Nov;126(11):1366–1372. doi: 10.1001/archsurg.1991.01410350056009. [DOI] [PubMed] [Google Scholar]
  28. Curtis R. E., Boice J. D., Jr, Stovall M., Bernstein L., Greenberg R. S., Flannery J. T., Schwartz A. G., Weyer P., Moloney W. C., Hoover R. N. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med. 1992 Jun 25;326(26):1745–1751. doi: 10.1056/NEJM199206253262605. [DOI] [PubMed] [Google Scholar]
  29. Delouche G., Bachelot F., Premont M., Kurtz J. M. Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys. 1987 Jan;13(1):29–34. doi: 10.1016/0360-3016(87)90256-2. [DOI] [PubMed] [Google Scholar]
  30. Delouche G., Bachelot F., Premont M., Kurtz J. M. Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys. 1987 Jan;13(1):29–34. doi: 10.1016/0360-3016(87)90256-2. [DOI] [PubMed] [Google Scholar]
  31. Eberlein T. J., Connolly J. L., Schnitt S. J., Recht A., Osteen R. T., Harris J. R. Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg. 1990 Jun;125(6):771–777. doi: 10.1001/archsurg.1990.01410180097016. [DOI] [PubMed] [Google Scholar]
  32. Fentiman I. S., Fagg N., Millis R. R., Hayward J. L. In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol. 1986 Sep;12(3):261–266. [PubMed] [Google Scholar]
  33. Findlay P., Goodman R. Radiation therapy for treatment of intraductal carcinoma of the breast. Am J Clin Oncol. 1983 Jun;6(3):281–285. doi: 10.1097/00000421-198306000-00005. [DOI] [PubMed] [Google Scholar]
  34. Fisher B., Anderson S., Fisher E. R., Redmond C., Wickerham D. L., Wolmark N., Mamounas E. P., Deutsch M., Margolese R. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991 Aug 10;338(8763):327–331. doi: 10.1016/0140-6736(91)90475-5. [DOI] [PubMed] [Google Scholar]
  35. Fisher B., Bauer M., Wickerham D. L., Redmond C. K., Fisher E. R., Cruz A. B., Foster R., Gardner B., Lerner H., Margolese R. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983 Nov 1;52(9):1551–1557. doi: 10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  36. Fisher B., Costantino J., Redmond C., Poisson R., Bowman D., Couture J., Dimitrov N. V., Wolmark N., Wickerham D. L., Fisher E. R. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989 Feb 23;320(8):479–484. doi: 10.1056/NEJM198902233200802. [DOI] [PubMed] [Google Scholar]
  37. Fisher B., Montague E., Redmond C., Barton B., Borland D., Fisher E. R., Deutsch M., Schwarz G., Margolese R., Donegan W. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer. 1977 Jun;39(6 Suppl):2827–2839. doi: 10.1002/1097-0142(197706)39:6<2827::aid-cncr2820390671>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  38. Fisher B., Redmond C., Dimitrov N. V., Bowman D., Legault-Poisson S., Wickerham D. L., Wolmark N., Fisher E. R., Margolese R., Sutherland C. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 1989 Feb 23;320(8):473–478. doi: 10.1056/NEJM198902233200801. [DOI] [PubMed] [Google Scholar]
  39. Fisher B., Redmond C., Fisher E. R., Bauer M., Wolmark N., Wickerham D. L., Deutsch M., Montague E., Margolese R., Foster R. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985 Mar 14;312(11):674–681. doi: 10.1056/NEJM198503143121102. [DOI] [PubMed] [Google Scholar]
  40. Fisher B., Redmond C., Fisher E. R., Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol. 1988 Jul;6(7):1076–1087. doi: 10.1200/JCO.1988.6.7.1076. [DOI] [PubMed] [Google Scholar]
  41. Fisher B., Redmond C., Poisson R., Margolese R., Wolmark N., Wickerham L., Fisher E., Deutsch M., Caplan R., Pilch Y. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30;320(13):822–828. doi: 10.1056/NEJM198903303201302. [DOI] [PubMed] [Google Scholar]
  42. Fisher B., Rockette H., Fisher E. R., Wickerham D. L., Redmond C., Brown A. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol. 1985 Dec;3(12):1640–1658. doi: 10.1200/JCO.1985.3.12.1640. [DOI] [PubMed] [Google Scholar]
  43. Fisher B., Wolmark N., Bauer M., Redmond C., Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981 Jun;152(6):765–772. [PubMed] [Google Scholar]
  44. Fisher E. R., Sass R., Fisher B., Wickerham L., Paik S. M. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer. 1986 Jan 15;57(2):197–208. doi: 10.1002/1097-0142(19860115)57:2<197::aid-cncr2820570203>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  45. Fisher J. C. The silicone controversy--when will science prevail? N Engl J Med. 1992 Jun 18;326(25):1696–1698. doi: 10.1056/NEJM199206183262511. [DOI] [PubMed] [Google Scholar]
  46. Fleck R., McNeese M. D., Ellerbroek N. A., Hunter T. A., Holmes F. A. Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):829–833. doi: 10.1016/0360-3016(89)90074-6. [DOI] [PubMed] [Google Scholar]
  47. Fornage B. D., Sneige N., Faroux M. J., Andry E. Sonographic appearance and ultrasound-guided fine-needle aspiration biopsy of breast carcinomas smaller than 1 cm3. J Ultrasound Med. 1990 Oct;9(10):559–568. doi: 10.7863/jum.1990.9.10.559. [DOI] [PubMed] [Google Scholar]
  48. Fornander T., Rutqvist L. E., Cedermark B., Glas U., Mattsson A., Silfverswärd C., Skoog L., Somell A., Theve T., Wilking N. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 1989 Jan 21;1(8630):117–120. doi: 10.1016/s0140-6736(89)91141-0. [DOI] [PubMed] [Google Scholar]
  49. Fowble B. L., Solin L. J., Schultz D. J., Goodman R. L. Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):269–277. doi: 10.1016/0360-3016(91)90771-u. [DOI] [PubMed] [Google Scholar]
  50. Frazier T. G., Copeland E. M., Gallager H. S., Paulus D. D., Jr, White E. C. Prognosis and treatment in minimal breast cancer. Am J Surg. 1977 Jun;133(6):697–701. doi: 10.1016/0002-9610(77)90156-8. [DOI] [PubMed] [Google Scholar]
  51. Frykberg E. R., Santiago F., Betsill W. L., Jr, O'Brien P. H. Lobular carcinoma in situ of the breast. Surg Gynecol Obstet. 1987 Mar;164(3):285–301. [PubMed] [Google Scholar]
  52. Gilliland M. D., Barton R. M., Copeland E. M., 3rd The implications of local recurrence of breast cancer as the first site of therapeutic failure. Ann Surg. 1983 Mar;197(3):284–287. doi: 10.1097/00000658-198303000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Grotting J. C., Urist M. M., Maddox W. A., Vasconez L. O. Conventional TRAM flap versus free microsurgical TRAM flap for immediate breast reconstruction. Plast Reconstr Surg. 1989 May;83(5):828–844. doi: 10.1097/00006534-198905000-00009. [DOI] [PubMed] [Google Scholar]
  54. Gump F. E., Jicha D. L., Ozello L. Ductal carcinoma in situ (DCIS): a revised concept. Surgery. 1987 Nov;102(5):790–795. [PubMed] [Google Scholar]
  55. Haagensen C. D., Lane N., Lattes R., Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer. 1978 Aug;42(2):737–769. doi: 10.1002/1097-0142(197808)42:2<737::aid-cncr2820420247>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  56. Halpern J., McNeese M. D., Kroll S. S., Ellerbroek N. Irradiation of prosthetically augmented breasts: a retrospective study on toxicity and cosmetic results. Int J Radiat Oncol Biol Phys. 1990 Jan;18(1):189–191. doi: 10.1016/0360-3016(90)90283-p. [DOI] [PubMed] [Google Scholar]
  57. Harris J. R., Connolly J. L., Schnitt S. J., Cady B., Love S., Osteen R. T., Patterson W. B., Shirley R., Hellman S., Cohen R. B. The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg. 1985 Feb;201(2):164–169. doi: 10.1097/00000658-198502000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Harris J. R., Levene M. B., Svensson G., Hellman S. Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979 Feb;5(2):257–261. doi: 10.1016/0360-3016(79)90729-6. [DOI] [PubMed] [Google Scholar]
  59. Hillner B. E., Smith T. J. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model. N Engl J Med. 1991 Jan 17;324(3):160–168. doi: 10.1056/NEJM199101173240305. [DOI] [PubMed] [Google Scholar]
  60. Holland R., Hendriks J. H., Vebeek A. L., Mravunac M., Schuurmans Stekhoven J. H. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 1990 Mar 3;335(8688):519–522. doi: 10.1016/0140-6736(90)90747-s. [DOI] [PubMed] [Google Scholar]
  61. Holmberg L., Zarén E., Adami H. O., Bergström R., Burns T. The patient's appraisal of the cosmetic result of segmental mastectomy in benign and malignant breast disease. Ann Surg. 1988 Feb;207(2):189–194. doi: 10.1097/00000658-198802000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Hortobagyi G. N., Buzdar A. U., Marcus C. E., Smith T. L. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr. 1986;(1):105–109. [PubMed] [Google Scholar]
  63. Hutter R. V., Snyder R. E., Lucas J. C., Foote F. W., Jr, Farrow J. H. Clinical and pathologic correlation with mammographic findings in lobular carcinoma in situ. Cancer. 1969 Apr;23(4):826–839. doi: 10.1002/1097-0142(196904)23:4<826::aid-cncr2820230417>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  64. Jacquemier J., Kurtz J. M., Amalric R., Brandone H., Ayme Y., Spitalier J. M. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer. 1990 Jun;61(6):873–876. doi: 10.1038/bjc.1990.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Janjan N. A., McNeese M. D., Buzdar A. U., Montague E. D., Oswald M. J. Management of locoregional recurrent breast cancer. Cancer. 1986 Oct 1;58(7):1552–1556. doi: 10.1002/1097-0142(19861001)58:7<1552::aid-cncr2820580728>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  66. Johnson C. H., van Heerden J. A., Donohue J. H., Martin J. K., Jr, Jackson I. T., Ilstrup D. M. Oncological aspects of immediate breast reconstruction following mastectomy for malignancy. Arch Surg. 1989 Jul;124(7):819–824. doi: 10.1001/archsurg.1989.01410070073015. [DOI] [PubMed] [Google Scholar]
  67. Jones S. E., Moon T. E., Bonadonna G., Valagussa P., Rivkin S., Buzdar A., Montague E., Powles T. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol. 1987 Oct;10(5):387–395. doi: 10.1097/00000421-198710000-00005. [DOI] [PubMed] [Google Scholar]
  68. Kantorowitz D. A., Poulter C. A., Rubin P., Patterson E., Sobel S. H., Sischy B., Dvoretsky P. M., Michalak W. A., Doane K. Treatment of breast cancer with segmental mastectomy alone or segmental mastectomy plus radiation. Radiother Oncol. 1989 Jun;15(2):141–150. doi: 10.1016/0167-8140(89)90128-x. [DOI] [PubMed] [Google Scholar]
  69. Kemeny M. M., Wellisch D. K., Schain W. S. Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer. Cancer. 1988 Sep 15;62(6):1231–1237. doi: 10.1002/1097-0142(19880915)62:6<1231::aid-cncr2820620631>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  70. Ketcham A. S., Moffat F. L. Vexed surgeons, perplexed patients, and breast cancers which may not be cancer. Cancer. 1990 Feb 1;65(3):387–393. doi: 10.1002/1097-0142(19900201)65:3<387::aid-cncr2820650302>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  71. Kroll S. S., Ames F., Singletary S. E., Schusterman M. A. The oncologic risks of skin preservation at mastectomy when combined with immediate reconstruction of the breast. Surg Gynecol Obstet. 1991 Jan;172(1):17–20. [PubMed] [Google Scholar]
  72. Kurtz J. M., Amalric R., Brandone H., Ayme Y., Jacquemier J., Pietra J. C., Hans D., Pollet J. F., Bressac C., Spitalier J. M. Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 1989 May 15;63(10):1912–1917. doi: 10.1002/1097-0142(19890515)63:10<1912::aid-cncr2820631007>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  73. Kurtz J. M., Jacquemier J., Amalric R., Brandone H., Ayme Y., Hans D., Bressac C., Roth J., Spitalier J. M. Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 1990 Apr 15;65(8):1867–1878. doi: 10.1002/1097-0142(19900415)65:8<1867::aid-cncr2820650833>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  74. Kurtz J. M., Jacquemier J., Amalric R., Brandone H., Ayme Y., Hans D., Bressac C., Spitalier J. M. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol. 1990 Apr;8(4):591–598. doi: 10.1200/JCO.1990.8.4.591. [DOI] [PubMed] [Google Scholar]
  75. Kurtz J. M., Jacquemier J., Torhorst J., Spitalier J. M., Amalric R., Hünig R., Walther E., Harder F., Almendral A., Brandone H. Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer. 1989 Apr 15;63(8):1630–1635. doi: 10.1002/1097-0142(19890415)63:8<1630::aid-cncr2820630833>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  76. Lagios M. D., Margolin F. R., Westdahl P. R., Rose M. R. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989 Feb 15;63(4):618–624. doi: 10.1002/1097-0142(19890215)63:4<618::aid-cncr2820630403>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  77. Lagios M. D., Westdahl P. R., Margolin F. R., Rose M. R. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer. 1982 Oct 1;50(7):1309–1314. doi: 10.1002/1097-0142(19821001)50:7<1309::aid-cncr2820500716>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  78. Larson D., Weinstein M., Goldberg I., Silver B., Recht A., Cady B., Silen W., Harris J. R. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys. 1986 Sep;12(9):1575–1582. doi: 10.1016/0360-3016(86)90280-4. [DOI] [PubMed] [Google Scholar]
  79. Levine M. N., Gent M., Hirsh J., Arnold A., Goodyear M. D., Hryniuk W., De Pauw S. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med. 1988 Feb 18;318(7):404–407. doi: 10.1056/NEJM198802183180703. [DOI] [PubMed] [Google Scholar]
  80. Levy S. M., Herberman R. B., Lee J. K., Lippman M. E., d'Angelo T. Breast conservation versus mastectomy: distress sequelae as a function of choice. J Clin Oncol. 1989 Mar;7(3):367–375. doi: 10.1200/JCO.1989.7.3.367. [DOI] [PubMed] [Google Scholar]
  81. Lindley R., Bulman A., Parsons P., Phillips R., Henry K., Ellis H. Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy. Surgery. 1989 Jan;105(1):13–20. [PubMed] [Google Scholar]
  82. Mansour E. G., Gray R., Shatila A. H., Osborne C. K., Tormey D. C., Gilchrist K. W., Cooper M. R., Falkson G. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989 Feb 23;320(8):485–490. doi: 10.1056/NEJM198902233200803. [DOI] [PubMed] [Google Scholar]
  83. Matthews R. H., McNeese M. D., Montague E. D., Oswald M. J. Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. Int J Radiat Oncol Biol Phys. 1988 Apr;14(4):659–663. doi: 10.1016/0360-3016(88)90086-7. [DOI] [PubMed] [Google Scholar]
  84. McGuire W. L. Adjuvant therapy of node-negative breast cancer. N Engl J Med. 1989 Feb 23;320(8):525–527. doi: 10.1056/NEJM198902233200811. [DOI] [PubMed] [Google Scholar]
  85. McGuire W. L., Clark G. M. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med. 1992 Jun 25;326(26):1756–1761. doi: 10.1056/NEJM199206253262607. [DOI] [PubMed] [Google Scholar]
  86. McGuire W. L., Tandon A. K., Allred D. C., Chamness G. C., Clark G. M. How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst. 1990 Jun 20;82(12):1006–1015. doi: 10.1093/jnci/82.12.1006. [DOI] [PubMed] [Google Scholar]
  87. Olivotto I. A., Rose M. A., Osteen R. T., Love S., Cady B., Silver B., Recht A., Harris J. R. Late cosmetic outcome after conservative surgery and radiotherapy: analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):747–753. doi: 10.1016/0360-3016(89)90061-8. [DOI] [PubMed] [Google Scholar]
  88. Paik S., Hazan R., Fisher E. R., Sass R. E., Fisher B., Redmond C., Schlessinger J., Lippman M. E., King C. R. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol. 1990 Jan;8(1):103–112. doi: 10.1200/JCO.1990.8.1.103. [DOI] [PubMed] [Google Scholar]
  89. Pierce S. M., Recht A., Lingos T. I., Abner A., Vicini F., Silver B., Herzog A., Harris J. R. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23(5):915–923. doi: 10.1016/0360-3016(92)90895-o. [DOI] [PubMed] [Google Scholar]
  90. Platt R., Zaleznik D. F., Hopkins C. C., Dellinger E. P., Karchmer A. W., Bryan C. S., Burke J. F., Wikler M. A., Marino S. K., Holbrook K. F. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med. 1990 Jan 18;322(3):153–160. doi: 10.1056/NEJM199001183220303. [DOI] [PubMed] [Google Scholar]
  91. Recht A., Danoff B. S., Solin L. J., Schnitt S., Connolly J., Botnick L., Goldberg I., Goodman R. L., Harris J. R. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol. 1985 Oct;3(10):1339–1343. doi: 10.1200/JCO.1985.3.10.1339. [DOI] [PubMed] [Google Scholar]
  92. Recht A., Silver B., Schnitt S., Connolly J., Hellman S., Harris J. R. Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys. 1985 Jul;11(7):1271–1276. doi: 10.1016/0360-3016(85)90241-x. [DOI] [PubMed] [Google Scholar]
  93. Rosen P. B., Jabs A. D., Kister S. J., Hugo N. E. Clinical experience with immediate breast reconstruction using tissue expansion or transverse rectus abdominis musculocutaneous flaps. Ann Plast Surg. 1990 Oct;25(4):249–257. doi: 10.1097/00000637-199010000-00002. [DOI] [PubMed] [Google Scholar]
  94. Rosen P. P., Braun D. W., Jr, Kinne D. E. The clinical significance of pre-invasive breast carcinoma. Cancer. 1980 Aug 15;46(4 Suppl):919–925. doi: 10.1002/1097-0142(19800815)46:4+<919::aid-cncr2820461311>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  95. Rosen P. P., Kosloff C., Lieberman P. H., Adair F., Braun D. W., Jr Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol. 1978 Sep;2(3):225–251. doi: 10.1097/00000478-197809000-00001. [DOI] [PubMed] [Google Scholar]
  96. Rosen P. P. Lobular carcinoma in situ and intraductal carcinoma of the breast. Monogr Pathol. 1984;(25):59–105. [PubMed] [Google Scholar]
  97. Rosen P. P., Senie R., Schottenfeld D., Ashikari R. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 1979 Mar;189(3):377–382. doi: 10.1097/00000658-197903000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Rosen P. R., Groshen S., Saigo P. E., Kinne D. W., Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol. 1989 Mar;7(3):355–366. doi: 10.1200/JCO.1989.7.3.355. [DOI] [PubMed] [Google Scholar]
  99. Rosner D., Bedwani R. N., Vana J., Baker H. W., Murphy G. P. Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg. 1980 Aug;192(2):139–147. doi: 10.1097/00000658-198008000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Rutgers E. J., van Slooten E. A., Kluck H. M. Follow-up after treatment of primary breast cancer. Br J Surg. 1989 Feb;76(2):187–190. doi: 10.1002/bjs.1800760227. [DOI] [PubMed] [Google Scholar]
  101. Sanger C. K., Reznikoff M. A comparison of the psychological effects of breast-saving procedures with the modified radical mastectomy. Cancer. 1981 Nov 15;48(10):2341–2346. doi: 10.1002/1097-0142(19811115)48:10<2341::aid-cncr2820481034>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  102. Sarrazin D., Lê M. G., Arriagada R., Contesso G., Fontaine F., Spielmann M., Rochard F., Le Chevalier T., Lacour J. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989 Mar;14(3):177–184. doi: 10.1016/0167-8140(89)90165-5. [DOI] [PubMed] [Google Scholar]
  103. Schain W., Edwards B. K., Gorrell C. R., de Moss E. V., Lippman M. E., Gerber L. H., Lichter A. S. Psychosocial and physical outcomes of primary breast cancer therapy: mastectomy vs excisional biopsy and irradiation. Breast Cancer Res Treat. 1983;3(4):377–382. doi: 10.1007/BF01807591. [DOI] [PubMed] [Google Scholar]
  104. Schmidt-Ullrich R., Wazer D. E., Tercilla O., Safaii H., Marchant D. J., Smith T. J., Homer M. A., Robert N. J. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):733–738. doi: 10.1016/0360-3016(89)90059-x. [DOI] [PubMed] [Google Scholar]
  105. Schnitt S. J., Connolly J. L., Khettry U., Mazoujian G., Brenner M., Silver B., Recht A., Beadle G., Harris J. R. Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer. 1987 Feb 15;59(4):675–681. doi: 10.1002/1097-0142(19870215)59:4<675::aid-cncr2820590402>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  106. Schnitt S. J., Connolly J. L., Recht A., Silver B., Harris J. R. Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer. 1989 Jul 15;64(2):448–454. doi: 10.1002/1097-0142(19890715)64:2<448::aid-cncr2820640218>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  107. Schwartz G. F., Patchefsky A. S., Feig S. A., Shaber G. S., Schwartz A. B. Clinically occult breast cancer. Multicentricity and implications for treatment. Ann Surg. 1980 Jan;191(1):8–12. doi: 10.1097/00000658-198001000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Seidman H., Gelb S. K., Silverberg E., LaVerda N., Lubera J. A. Survival experience in the Breast Cancer Detection Demonstration Project. CA Cancer J Clin. 1987 Sep-Oct;37(5):258–290. doi: 10.3322/canjclin.37.5.258. [DOI] [PubMed] [Google Scholar]
  109. Silverstein M. J., Gierson E. D., Colburn W. J., Rosser R. J., Waisman J. R., Gamagami P. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg Gynecol Obstet. 1991 Mar;172(3):211–214. [PubMed] [Google Scholar]
  110. Singletary S. E., McNeese M. D., Hortobagyi G. N. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer. 1992 Jun 1;69(11):2849–2852. doi: 10.1002/1097-0142(19920601)69:11<2849::aid-cncr2820691134>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  111. Singletary S. E., McNeese M. Segmental mastectomy and irradiation in the treatment of breast cancer. Am J Clin Oncol. 1988 Dec;11(6):679–683. doi: 10.1097/00000421-198812000-00019. [DOI] [PubMed] [Google Scholar]
  112. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987 Jan 9;235(4785):177–182. doi: 10.1126/science.3798106. [DOI] [PubMed] [Google Scholar]
  113. Solin L. J., Fowble B., Martz K., Pajak T. F., Goodman R. L. Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1986 May;12(5):721–725. doi: 10.1016/0360-3016(86)90028-3. [DOI] [PubMed] [Google Scholar]
  114. Stotter A. T., McNeese M. D., Ames F. C., Oswald M. J., Ellerbroek N. A. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer. 1989 Dec 1;64(11):2217–2225. doi: 10.1002/1097-0142(19891201)64:11<2217::aid-cncr2820641106>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  115. Stotter A. T., McNeese M., Oswald M. J., Ames F. C., Romsdahl M. M. The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int J Radiat Oncol Biol Phys. 1990 Feb;18(2):283–287. doi: 10.1016/0360-3016(90)90090-7. [DOI] [PubMed] [Google Scholar]
  116. Sunshine J. A., Moseley H. S., Fletcher W. S., Krippaehne W. W. Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up. Am J Surg. 1985 Jul;150(1):44–51. doi: 10.1016/0002-9610(85)90008-x. [DOI] [PubMed] [Google Scholar]
  117. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  118. Taghian A., de Vathaire F., Terrier P., Le M., Auquier A., Mouriesse H., Grimaud E., Sarrazin D., Tubiana M. Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys. 1991 Jul;21(2):361–367. doi: 10.1016/0360-3016(91)90783-z. [DOI] [PubMed] [Google Scholar]
  119. Tandon A. K., Clark G. M., Chamness G. C., Chirgwin J. M., McGuire W. L. Cathepsin D and prognosis in breast cancer. N Engl J Med. 1990 Feb 1;322(5):297–302. doi: 10.1056/NEJM199002013220504. [DOI] [PubMed] [Google Scholar]
  120. Tandon A. K., Clark G. M., Chamness G. C., Ullrich A., McGuire W. L. HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol. 1989 Aug;7(8):1120–1128. doi: 10.1200/JCO.1989.7.8.1120. [DOI] [PubMed] [Google Scholar]
  121. Tomin R., Donegan W. L. Screening for recurrent breast cancer--its effectiveness and prognostic value. J Clin Oncol. 1987 Jan;5(1):62–67. doi: 10.1200/JCO.1987.5.1.62. [DOI] [PubMed] [Google Scholar]
  122. Tormey D. C., Gray R., Taylor S. G., 4th, Knuiman M., Olson J. E., Cummings F. J. Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer. NCI Monogr. 1986;(1):75–80. [PubMed] [Google Scholar]
  123. Valagussa P., Tancini G., Bonadonna G. Second malignancies after CMF for resectable breast cancer. J Clin Oncol. 1987 Aug;5(8):1138–1142. doi: 10.1200/JCO.1987.5.8.1138. [DOI] [PubMed] [Google Scholar]
  124. Veronesi U., Salvadori B., Luini A., Banfi A., Zucali R., Del Vecchio M., Saccozzi R., Beretta E., Boracchi P., Farante G. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg. 1990 Mar;211(3):250–259. [PMC free article] [PubMed] [Google Scholar]
  125. Vinton A. L., Traverso L. W., Zehring R. D. Immediate breast reconstruction following mastectomy is as safe as mastectomy alone. Arch Surg. 1990 Oct;125(10):1303–1308. doi: 10.1001/archsurg.1990.01410220087012. [DOI] [PubMed] [Google Scholar]
  126. Weidner N., Semple J. P., Welch W. R., Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991 Jan 3;324(1):1–8. doi: 10.1056/NEJM199101033240101. [DOI] [PubMed] [Google Scholar]
  127. Wheeler J. E., Enterline H. T., Roseman J. M., Tomasulo J. P., McIlvaine C. H., Fitts W. T., Jr, Kirshenbaum J. Lobular carcinoma in situ of the breast. Long-term followup. Cancer. 1974 Sep;34(3):554–563. doi: 10.1002/1097-0142(197409)34:3<554::aid-cncr2820340313>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  128. Winchester D. P., Sener S. F., Khandekar J. D., Oviedo M. A., Cunningham M. P., Caprini J. A., Burkett F. E., Scanlon E. F. Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer. 1979 Mar;43(3):956–960. doi: 10.1002/1097-0142(197903)43:3<956::aid-cncr2820430326>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  129. Wobbes T., Tinnemans J. G., van der Sluis R. F. Residual tumour after biopsy for non-palpable ductal carcinoma in situ of the breast. Br J Surg. 1989 Feb;76(2):185–186. doi: 10.1002/bjs.1800760226. [DOI] [PubMed] [Google Scholar]
  130. Zafrani B., Fourquet A., Vilcoq J. R., Legal M., Calle R. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer. 1986 Apr 1;57(7):1299–1301. doi: 10.1002/1097-0142(19860401)57:7<1299::aid-cncr2820570708>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  131. Zucali R., Luini A., Del Vecchio M., Sacchini V., Sverzellati E., Stucchi C., Banfi A., Veronesi U. Contralateral breast cancer after limited surgery plus radiotherapy of early mammary tumors. Eur J Surg Oncol. 1987 Oct;13(5):413–417. [PubMed] [Google Scholar]
  132. le Doussal V., Tubiana-Hulin M., Hacene K., Friedman S., Brunet M. Nuclear characteristics as indicators of prognosis in node negative breast cancer patients. Breast Cancer Res Treat. 1989 Nov;14(2):207–216. doi: 10.1007/BF01810737. [DOI] [PubMed] [Google Scholar]
  133. van Dongen J. A., Holland R., Peterse J. L., Fentiman I. S., Lagios M. D., Millis R. R., Recht A. Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. Eur J Cancer. 1992;28(2-3):626–629. doi: 10.1016/s0959-8049(05)80113-3. [DOI] [PubMed] [Google Scholar]
  134. von Rueden D. G., Wilson R. E. Intraductal carcinoma of the breast. Surg Gynecol Obstet. 1984 Feb;158(2):105–111. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES